Bococizumab is a cutting-edge anti-PCSK9 antibody specifically developed to address hypercholesterolemia. Such therapeutic agent works by the PCSK9 protein, a critical regulator of cholesterol levels. By blocking the https://poppyhris752372.wikipublicity.com/8415785/bococizumab_a_novel_anti_pcsk9_antibody_for_hypercholesterolemia